Company Profile

RVTY insider trades (13 months) →

Today's multi-factor rank: 301 of 466 · see the ranking

Quant500 Scores

Momentum

5.7/10

Value

4.5/10

Growth

4.3/10

Quality

4.5/10

Multifactor

4.8/10

Market and Valuation

Price & Market

Prev Close Price:$146.73

Open:$146.50

Day's Low:$142.45

Day's High:$146.89

Bid / Ask:-

Market Cap:16.01B

Enterprise Value:18.33B

52-Week Range

52-Week Low:$81.22

52-Week High:$149.52

Current position in 52-week range

52w Low-52w High

50-Day Avg:$120.22

200-Day Avg:$103.89

Volume

Volume Today:3,321,311

Avg Volume (3m):1,666,604

Avg Volume (10d):2,211,770

52-Week Change:+65.42%

vs S&P 500, 52 weeks:-

Beta:1.09

Valuation Multiples

PER Trailing:70.32

PER Forward:24.34

PEG Ratio:0.73

Price / Book:2.21

Price / Sales (TTM):5.50

EV / Revenue:6.29

EV / EBITDA:20.92

Dividends

Current yield:0.19%

Annual Dividend Rate:$0.28

Dividend Trailing:$0.28

Yield Trailing:0.19%

5-Year Avg Yield:0.24%

Payout Ratio:13.46%

Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-

Fiscal Year (Next):-

Date Filter (Month):

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):2.91B

Gross Profit:1.60B

EBITDA:875.83M

Net Income (TTM):237.37M

Rev Growth (YoY):+1.30%

Earnings Growth (YoY):+1.20%

Quarterly earnings growth (YoY):-3.90%

Margins

Gross Margin:-

EBITDA Margin:-

Operating Margin:-

Net Margin:-

Per Share

EPS Trailing (TTM):-

EPS Forward (Est.):$5.89

Revenue Per Share:$25.77

Cash Per Share:-

Book Value:$64.78

Last Dividend:-

Ex-Dividend Date:-

Last Split:-

Balance Sheet & Liquidity

Total cash:1.02B

Total Debt:3.34B

Net Debt (Debt - Cash):2.32B

Debt / Equity:46.23%

Current Ratio:1.80

Quick Ratio:1.36

Cash Flows

Operating Cash Flow:627.63M

Free Cash Flow (FCF):604.99M

FCF Yield (FCF / Market Cap):-

Enterprise Value:18.33B

EV / Revenue:6.29

EV / EBITDA:20.92

Profitability

ROE (Return on Equity):3.21%

ROA (Return on Assets):2.37%

PER Trailing:70.32

PER Forward:24.34

Price / Book:2.21

PEG Ratio:0.73

52-Week Change:+65.42%

S&P 500 change, 52 weeks:+14.80%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$2.04

EPS Forward (Est.):$5.89

PER Forward:-

PEG Ratio:0.73

Growth and Margins

Earnings Growth YoY:-

Quarterly Earnings Growth YoY:-

Rev Growth YoY:-

Net Margin:-

Gross Margin:-

EBITDA Margin:-

Per Share

Revenue Per Share:$25.77

Cash Per Share:-

Book Value:$64.78

Cash Flows (TTM)

Free Cash Flow:604.99M

Operating Cash Flow:627.63M

EBITDA:875.83M

Total Revenue (TTM):2.91B

Net Income (TTM):237.37M

Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter	Period	Actual EPS	Estimated EPS	Difference	Surprise %	Currency

Ownership Structure

Ownership Distribution

% Insiders:-

% Institutional:-

% Inst. (of Float):-

No. of Institutions:-

Visual distribution

InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:111,586,401

Float (free shares):102,484,298

Short interest (shares):6,305,681

Short % of float:-

Short Ratio (days to cover):4.14

Short interest, prior month:-

Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-

Audit Risk:-

Board risk:-

Compensation Risk:-

Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization	Report Date	% Shares	No. Shares	Value (USD)	Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund	Report Date	% Shares	No. Shares	Value (USD)	Change %

Recent Insider Trades

Executive / Insider	Title	Date	Action	Shares

Options Chain

Expiration Date:

CALLS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

PUTS

Strike	Last	Bid	Ask	Vol.	O.I.	IV

Revvity, Inc. (RVTY) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type	Date	Official link
10-Q	2026-08-11	View filing ↗
8-K	2026-08-04	View filing ↗
11-K	2026-06-23	View filing ↗
SD	2026-06-01	View filing ↗
10-Q	2026-05-12	View filing ↗
8-K	2026-05-05	View filing ↗
8-K	2026-05-01	View filing ↗
DEFA14A	2026-03-16	View filing ↗
PRE 14A	2026-03-06	View filing ↗
10-K	2026-02-24	View filing ↗

Company and Executive Profile

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

General Information

Headquarters:United States

City:Waltham

Employees:11,000

Sector:Healthcare

Industry:Diagnostics & Research

Website:-

Key Executives

Name	Title	Age	Total pay
Dr. Prahlad R. Singh Ph.D.	CEO, President & Director	60	3.56M
Mr. Maxwell Krakowiak	Senior VP & CFO	35	1.18M
Mr. Tajinder S. Vohra	Senior Vice President of Global Operations	59	1.03M
Mr. Joel S. Goldberg	Senior VP of Administration, General Counsel & Secretary	56	1.25M
Ms. Miriame Victor	Senior Vice President & Chief Business Officer	44	1.04M
Ms. Anita Gonzales	Chief Accounting Officer, VP & Controller	49	-
Mr. Bryan A. Kipp	Senior VP of Technology & Licensing	-	-
Dr. Madhuri Hegde FACMG, Ph.D.	Senior VP & Chief Scientific Officer	-	-

You have seen the engine room

Few finance sites let you get this far, and none we know of also shows you where its knowledge ends. If this way of working convinces you, the thing almost nobody catches in time can reach you by email: the big insider buys — executives and major shareholders putting in their own money — the same day they report them to the SEC, with the Form 4 linked. It takes three steps and none of them costs anything: create the account, confirm the email we send you, then switch the alert on in your profile (the icon at the top right). It starts off and it goes off again with the same click. Along the way all three are saved: your simulator portfolios, your personal portfolio and your Academy progress, synced across devices.

No card. No spam.

Revvity, Inc. (RVTY): Quantitative Analysis

Name: Factor scores for Revvity, Inc. (RVTY)
Creator: Quant500
License: https://quant500.com/legal

Revvity, Inc. (RVTY) — Healthcare — Diagnostics & Research. RVTY is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, RVTY has returned +48.5% against +12.2% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Sep 18, 2026.

RVTY ranks 301 of 466 on today's multifactor score, and 40 of the 55 Healthcare companies that score. Its strongest factor is momentum (Z 0.43, ranked 133 of 497); its weakest is growth (Z -0.44, ranked 405 of 494). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.

Factor scores

The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.

Factor	Z-Score	Rank
Multifactor	-0.144	301 of 466 ↑22
Momentum	0.429	133 of 497 ↑27
Value	-0.271	298 of 494 ↑6
Quality	-0.290	322 of 473 =
Growth	-0.443	405 of 494 =

Market data

Metric	Value
Price	$143.45
Market Cap	16.01B
P/E	70.32
Revenue (last 12 months)	2.91B
Price / book	2.21
Book value per share	$64.78
52-week range	$81.22 – $149.52
Dividend yield	0.19%
Beta	1.09
Average volume	1,666,604
Shares outstanding	111.59M
Short interest (% of float)	8.47% (as of Aug 31, 2026)

When does RVTY report earnings? 12 of its last 12, before the open →

What are RVTY insiders doing? 50 transactions filed with the SEC, of them 8 sells, the last one on Aug 25, 2026 →

Data as of Sep 18, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

Company Profile

Market and Valuation

Price & Market

52-Week Range

Volume

Valuation Multiples

Dividends

Valuation Context

Financial Statements TTM (Trailing 12 Months)

Income Statement

Margins

Per Share

Balance Sheet & Liquidity

Cash Flows

Profitability

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

Growth and Margins

Per Share

Cash Flows (TTM)

EPS Surprise History - Last 4 Quarters

Ownership Structure

Ownership Distribution

Shares & Short Interest

Governance Score (1=Best, 10=Worst)

Top Institutional Holders

Top Mutual Funds

Recent Insider Trades

Options Chain

CALLS

PUTS

Sentiment Metrics

Expected move

Revvity, Inc. (RVTY) SEC filings: 10-K, 10-Q and 8-K

Company and Executive Profile

General Information

Key Executives

You have seen the engine room

Revvity, Inc. (RVTY): Quantitative Analysis

Factor scores

Market data